JPH03505744A - サイトカラシン組成物および治療法 - Google Patents

サイトカラシン組成物および治療法

Info

Publication number
JPH03505744A
JPH03505744A JP2507126A JP50712690A JPH03505744A JP H03505744 A JPH03505744 A JP H03505744A JP 2507126 A JP2507126 A JP 2507126A JP 50712690 A JP50712690 A JP 50712690A JP H03505744 A JPH03505744 A JP H03505744A
Authority
JP
Japan
Prior art keywords
cytochalasin
cytochalasins
administration
group
immunosuppression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2507126A
Other languages
English (en)
Japanese (ja)
Inventor
フォンディ，トーマス，ピー
ボーギヨー，デニス
Original Assignee
シラキューズ　ユニバーシティ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シラキューズ　ユニバーシティ filed Critical シラキューズ　ユニバーシティ
Publication of JPH03505744A publication Critical patent/JPH03505744A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2507126A 1989-04-28 1990-04-27 サイトカラシン組成物および治療法 Pending JPH03505744A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34501089A 1989-04-28 1989-04-28
US345,010 1989-04-28

Publications (1)

Publication Number Publication Date
JPH03505744A true JPH03505744A (ja) 1991-12-12

Family

ID=23353087

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2507126A Pending JPH03505744A (ja) 1989-04-28 1990-04-27 サイトカラシン組成物および治療法

Country Status (4)

Country Link
EP (1) EP0429585A4 (fr)
JP (1) JPH03505744A (fr)
CA (1) CA2031520A1 (fr)
WO (1) WO1990013293A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009069668A1 (fr) * 2007-11-28 2009-06-04 National University Corporation Nagoya University Agent pour augmenter l'expression d'un antigène du mélanome malin, et son utilisation

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250563A (en) * 1991-09-25 1993-10-05 Merck & Co., Inc. Inhibitors of HIV protease
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
WO1993011763A1 (fr) * 1991-12-09 1993-06-24 Usher Thomas C Utilisation de cytochalasines pour inhiber la replication virale
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5342926A (en) * 1993-06-08 1994-08-30 The Regents Of The University Of California Analogs of cytochalasin B as radiopharmaceuticals for nuclear imaging of trans-membrane glucose transport
EP0975340B2 (fr) † 1997-03-31 2009-10-28 Boston Scientific Limited Inhibiteur therapeutique des cellules des muscles lisses de la paroi vasculaire
CA2312778A1 (fr) * 1997-12-04 1999-06-10 Hadasit Medical Research Services And Development Ltd. Traitement chimio et immunotherapeutique combine a l'aide de medicaments et de cytokines encapsules dans des liposomes
US6787132B1 (en) * 1997-12-04 2004-09-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Combined chemo-immunotherapy with liposomal drugs and cytokines
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
US11007176B2 (en) 2019-02-19 2021-05-18 Tzu Chi University Use of actin depolymerizing agents for the treatment of anxiety disorders
CN110563634B (zh) * 2019-09-09 2020-12-08 湖南省中医药研究院 吲哚细胞松弛素类化合物及其制备方法和应用
CN111249445B (zh) * 2020-02-27 2022-11-15 广东医科大学 一种细胞松弛素h软胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1289077C (fr) * 1984-08-13 1991-09-17 Harry H. Leveen Traitement du cancer a l'aide de la phlorizine et de ses derives
AU1969388A (en) * 1987-06-19 1989-01-19 Syracuse University Cytochalasin purification methods and compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009069668A1 (fr) * 2007-11-28 2009-06-04 National University Corporation Nagoya University Agent pour augmenter l'expression d'un antigène du mélanome malin, et son utilisation

Also Published As

Publication number Publication date
CA2031520A1 (fr) 1990-10-29
WO1990013293A1 (fr) 1990-11-15
EP0429585A1 (fr) 1991-06-05
EP0429585A4 (en) 1992-03-25

Similar Documents

Publication Publication Date Title
EP0004467B1 (fr) Bis-anthracyclines, méthodes pour les préparer et pour les utiliser, et compositions à base de liposomes pour les administrer
JPH03505744A (ja) サイトカラシン組成物および治療法
JP2007535525A (ja) β−カルボリン誘導体を含有する医薬組成物および癌を処置するためのそれらの使用
DE69928093T2 (de) Kombinationspräparat enthaltend monozyten-abgeleitete zellen zur behandlung von neoplastischen oder infektiösen erkrankungen
EA014070B1 (ru) Применение растительной композиции для лечения воспалительных нарушений
US20210332062A1 (en) Hetero-substituted cyclic lactone analogues and uses thereof
CA2363670A1 (fr) Composes chimiques
EP0344880A2 (fr) Compositions pharmaceutiques à activité anticancéreuse
US5250296A (en) Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fluorouridine
JP4454051B2 (ja) 新規な糖脂質、その製造方法及びその用途
EP2958569B1 (fr) Hétérocycles phosphorés analogues de sucres à activité antimétastatique
WO2005000291A1 (fr) Methode de traitement de la fibrose pulmonaire idiopathique au moyen de derives de triptolide
US6267968B1 (en) MDP derivatives and conjugates having haematipoietic function stimulating activity, and compositions containing same
JP2002535251A (ja) 癌治療のための新規化合物
KR0185226B1 (ko) 이식 조직의 거부반응 억제제 및 il-1 생산 억제제
CA3004107C (fr) Composes glycolipides et leurs utilisations dans le traitement de tumeurs
JP2006182785A (ja) 造血機能に関して刺激活性を示すｍｄｐ誘導体および複合体ならびにそれらを含む組成物
JPH02304058A (ja) キサントシリンｘモノメチルエーテル誘導体及びそれを含有する抗腫瘍剤
JPS632922A (ja) ドラツグキヤリア
JP3246670B2 (ja) インターロイキン−２と５’−デオキシ−５−フルオロウリジンとを含有してなる抗癌剤
JP3660230B2 (ja) 天然型抗腫瘍性又は抗ウイルス性物質およびその用途
Tibell et al. Cyclosporine A in fat emulsion carrier: immunosuppressive effect in vitro
JP6281901B2 (ja) 水溶性ポルフィリン誘導体とそれらの製造方法
KR20050039700A (ko) 이식거부 치료용 화합물 및 치료 방법
JPS63264409A (ja) 制癌剤